drugset / Trial / NCT02990455

Reduced Nicotine Cigarettes in Smokers With and Without Alcohol Use Disorder

NCT02990455 ↗

Phase 1 Completed 47 enrolled Battelle Memorial Institute
RandomizedCrossoverDouble-blindBasic science

Summary

The proposed research will investigate whether smokers with vs. without current at-risk alcohol drinking (ARD) respond to reduced nicotine cigarettes by increasing their alcohol consumption or smoke exposure, thereby diminishing the hypothesized public health benefit of these new products.

Timeline

Start
2017-11-14
Primary completion
2021-04-21
Completion
2021-04-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Reduced Nicotine Cigarettes Unknown 0.03 mg Inhaled
Subject Reduced Nicotine Cigarettes Unknown 0.8 mg Inhaled